Clinical utility of measuring both glutamic acid decarboxylase antibodies and islet cell antibodies in the diagnosis of latent autoimmune diabetes in adults – is it cost-effective?
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.